From July 1, 2022 to September 30, 2022, the company has repurchased 1,266,150 shares, representing 0.76% for CNY 26.09 million. With this, the company has completed the repurchase of 1,522,850 shares, representing 0.92% for CNY 30.95 million under the buyback announced on April 22, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.18 CNY | -0.78% | -2.02% | -29.60% |
05-23 | Hvsen Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024 | CI |
04-25 | Hvsen Biotechnology Co., Ltd. Proposes Final Cash Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.60% | 231M | |
-13.59% | 78.17B | |
+21.62% | 3.62B | |
-5.56% | 3.09B | |
+13.68% | 1.68B | |
-5.27% | 1.3B | |
-29.81% | 1.18B | |
-31.11% | 1.15B | |
-22.47% | 1.02B | |
-3.22% | 926M |
- Stock Market
- Equities
- 300871 Stock
- News Hvsen Biotechnology Co., Ltd.
- Tranche Update on Hvsen Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 22, 2022.